PDK1 and breast carcinoma: In the same model, it is also curious that levels of S241-phosphorylated PDK1 in lapatinib-treated animals exceeded those in PBS controls (or indeed JBS2 + lapatinib-treated animals), as lapatinib reportedly downregulates phospho-PDK1 (S241) in breast cancer cells [41].